HomeGreater Than Icon
Mutual FundsGreater Than Icon
Compare Mutual FundsGreater Than Icon
DSP Large & Mid Cap Fund - Direct (G) vs Nippon India Pharma Fund - Direct (G)

DSP Large & Mid Cap Fund - Direct (G) vs Nippon India Pharma Fund - Direct (G)

stock1

DSP Large & Mid Cap Fund - Direct (G)

12.62%

stock2

Nippon India Pharma Fund - Direct (G)

17.63%

Graph not available
Graph not available

About Fund

Citibank N.A.

Computer Age Management Services (P) Ltd.

Deutsche Bank AG

Karvy Computershare Pvt. Ltd.

Very High Risk

100

14386.91

1.76

679.383

January 1, 2013

0

Very High Risk

5000

8259.60

1.12

560.8615

January 1, 2013

1

27.77 %

24.04 %

12.62 %

23.13 %

24.37 %

17.63 %

Apoorva Shah

B.Com., PGDM (IIM Ahmedabad) Post graduate diploma in management from the indian institute of management.

He joined DSP BlackRock Investment Managers Pvt. Ltd. (previously called DSP Merrill Lynch Fund Managers) in April 2006. He previously held senior positions in the Global Private Client and Institutional Equity Sales divisions of DSP Merrill Lynch Ltd. Over 25 years of experience in banking and investment,

Rohit Singhania

B.Com. MMS

Over 18 years of experience as detailed under: From September, 2005 to present: Joined as Portfolio Analyst in firm's PMS division. Transferred to Equities Investment team in June 2009 as Research Analyst. Previously, he was with HDFC Securities Limited as a part of its Institutional Equities Research Desk. He spent 13 months at HDFC Securities as Sr. Equity Analyst. Prior to HDFC securities, he was employed with IL&FS Investmart Limited as Equity Analyst.

Sailesh Raj Bhan

MBA (Finance), CFA.

Mr.Bhan is an MBA with specialization in Finance and CFA. Has over 9 Yrs. of experience in Equity Securities Research & Sequeir Investment Pvt. Ltd. for 5 years and with Emkay Share & stock Broker Pvt. Ltd. for 2 years.

Get your FAQs right

When comparing DSP Large & Mid Cap Fund - Direct (G) vs Nippon India Pharma Fund - Direct (G), consider factors such as historical performance, expense ratios, investment strategy, risk level, and the fund manager's credibility. Moreover, look at asset allocation and how each fund fits your investment goals.
Yes, you can invest in both DSP Large & Mid Cap Fund - Direct (G) and Nippon India Pharma Fund - Direct (G) at the same time. This can help diversify your portfolio and balance risk, provided the fund manager's investment strategies streamline each other.
While comparing DSP Large & Mid Cap Fund - Direct (G) and Nippon India Pharma Fund - Direct (G), the portfolio turnover ratio indicates how frequently assets within the fund are bought and sold. A high turnover may lead to higher transaction costs and tax implications, while a low turnover ratio indicates a buy-and-hold strategy.
Yes, you can typically switch between DSP Large & Mid Cap Fund - Direct (G) and Nippon India Pharma Fund - Direct (G), subject to the fund's policies and any applicable fees. It is important to consider potential tax implications and the timing of your switch.
Yes, you can compare DSP Large & Mid Cap Fund - Direct (G) and Nippon India Pharma Fund - Direct (G) based on their dividend payouts. Look at dividends profit, consistency, and growth, as these factors can influence your overall return on investment.

Join the Future of Trading

with BlinkX

#ItsATraderThing

Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions